EUVIMEDEUVIMED entdecken
Open Access

Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target

Tomasz J Guzik

European Heart Journal: Acute Cardiovascular Care · 29.10.2026 · 15 (10) · 739-740

DOI: 10.1093/ehjacc/zuag124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 19.10.2026. Verfasst von Tomasz J Guzik. Beteiligte Einrichtung: Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh EH16 4TJ, UK. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: British Heart Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial refers to ‘Associations between admission C-reactive protein and in-hospital mortality amongst patients with cardiogenic shock’ by S. Mendelsohn et al., published in this issue. Therapeutic options in cardiogenic shock remain largely limited. Over the past two decades, the field has refined haemodynamic staging, and the SCAI classification now describes the severity of a patient's condition with reasonable precision.1 It, however, does not provide prognostic value; we would need to understand why two patients at the same stage can follow different courses. Mendelsohn et al.,2 in this issue of the journal, examine one candidate explanation, systemic inflammation, using the most widely available biomarker in routine practice.2 The study builds on the Vizient Clinical Data Base and identifies 26 525 adults with a discharge code for cardiogenic shock, a C-reactive protein (CRP) measurement within 2 days of admission, and no coded sepsis. In-hospital mortality rose from 28.7% in the lowest CRP tertile to 42.3% in the highest. After inverse probability weighting, the absolute excess mortality was 3.9% in the middle tertile and 12.4% in the top tertile. The gradient persisted when CRP was restricted to day one, when the cohort was split by heart failure or myocardial infarction as the admission diagnosis, and within C and D stages of the SCAI. Each 50 mg/L increase in CRP was associated with a 19% increase in mortality.

Autor:innen und Institutionen

  • Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh EH16 4TJ, UK.
  • National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.
  • Department of Internal Medicine, Jagiellonian University Collegium Medicum, Krakow Military Hospital, ul. Wrocławska 1-3, Kraków 31-130, Poland.

Förderung

  • British Heart Foundation

Zitieren

APA

Guzik, T. J. (2026). Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target. European Heart Journal: Acute Cardiovascular Care, 15(10), 739-740. https://doi.org/10.1093/ehjacc/zuag124

Vancouver

Guzik TJ. Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target. European Heart Journal: Acute Cardiovascular Care. 2026;15(10):739-740. doi:10.1093/ehjacc/zuag124

BibTeX
@article{Guzik2026,
  author = {Guzik, Tomasz J},
  title = {Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {739--740},
  doi = {10.1093/ehjacc/zuag124}
}
Kostenlos starten →